The players are listed below, descending by service time (years.days):
It’s been a rising trend in MLB for teams to provide club options and buyouts to arbitration-eligible players, as seen here with Taylor Walls, which sets an upper limit to what a player could earn during his arbitration years. In Walls’s case, his performance likely did not rise above the level that would correspond to the option price option, so the Rays could exercise the buyout and go to arbitration, hoping to save around half a million dollars. Or they could keep things simple and use the option anyway to avoid wading through one of the most human elements of the game: aggravation over what you’re paid.
Another interesting arbitration case will be that of Griffin Jax. He’s been openly discussed as a potential starter for next season, almost since the moment he was acquired for starter Taj Bradley. Transitioning to the rotation would raise his future earning potential but it may come with additional injury risks. Buying out his arbitration years to guarantee his 2027 salary would transfer some of that risk from the player to the team, align everyone’s interests, and simplify the relationship so that players, coaches, and trainers can focus more purely on baseball.
A model for that type of contract can be seen in the one signed by Drew Rasmussen before his post-injury return to the rotation — the Rays bought out the remaining arb years and added a club option at the end. An example of the situation to avoid in this case is that of Garrett Crochet in Chicago, where the pitcher made it known that he didn’t want to pitch in the postseason (blowing past his previous innings totals) without a contract extension to alleviate his risk and pay him at starting pitcher rates (above what he would have gotten in arbitration).
Some of the other players listed above are already coming off years lost to injury, such as Shane McClanahan, Stuart Fairchild, Alex Faedo, Richie Palacios, and Manny Rodriguez. Not all of them might make it to the next 40-man roster.
Some healthy players might also be candidates to be cut or traded, particularly part time role players like Chistopher Morel or Cole Sulser, whose profiles are (for them, unfortunately) plentiful on the open market.
